Literature DB >> 28351793

Nivolumab-Associated Colitis Mimicking Ulcerative Colitis.

Kimitoshi Kubo1, Mototsugu Kato1, Katsuhiro Mabe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28351793     DOI： 10.1016/j.cgh.2017.03.026

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  8 in total

1.  Readministration of Nivolumab after Persistent Immune-related Colitis in a Patient with Recurrent Melanoma.

Authors:  Yosuke Fujii; Yoshitaka Nishikawa; Motoo Nomura; Shin'ich Miyamoto; Yu Uneno; Takahiro Horimatsu; Manabu Muto
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

2.  Safe Use of Nivolumab in a Patient with Epipharyngeal Carcinoma and Preexisting Ulcerative Colitis: A Histologically Proven Case Report.

Authors:  Yasuki Hijikata; Yasuo Matsubara; Yasunori Ota; Lay Ahyoung Lim; Kenzaburo Tani; Yoshihiro Hirata; Hiroshi Yotsuyanagi
Journal:  Intern Med       Date:  2020-02-01       Impact factor: 1.271

Review 3.  The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review.

Authors:  Ryosuke Yamauchi; Toshihiro Araki; Keiichi Mitsuyama; Takaaki Tokito; Hidenobu Ishii; Shinichiro Yoshioka; Kotaro Kuwaki; Atsushi Mori; Tetsuhiro Yoshimura; Osamu Tsuruta; Takuji Torimura
Journal:  BMC Gastroenterol       Date:  2018-08-31       Impact factor: 3.067

4.  Remission of ulcerative colitis flare-up induced by nivolumab.

Authors:  Maho Iwamoto; Kimitoshi Kato; Mitsuhiko Moriyama; Kenya Yamaguchi; Satoru Takahashi
Journal:  Int J Colorectal Dis       Date:  2020-05-26       Impact factor: 2.571

Review 5.  Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management.

Authors:  Liansha Tang; Jialing Wang; Nan Lin; Yuwen Zhou; Wenbo He; Jiyan Liu; Xuelei Ma
Journal:  Front Immunol       Date:  2021-12-21       Impact factor: 7.561

6.  Endoscopic and histopathologic features of Anti-PD-1-related collagenous colitis.

Authors:  Hidezumi Kikuchi; Hirotake Sakuraba; Yui Akemoto; Kazuhiro Hosoi; Yasuhisa Murai; Kentaro Hoshi; Yukari Fukutoku; Taka Asari; Yohei Sawada; Keisuke Hasui; Tetsuya Tatsuta; Hiroto Hiraga; Daisuke Chinda; Tatsuya Mikami; Shinsaku Fukuda
Journal:  DEN open       Date:  2022-01-11

7.  Severe Gastritis after Administration of Nivolumab and Ipilimumab.

Authors:  Yoshito Nishimura; Miho Yasuda; Kazuki Ocho; Masaya Iwamuro; Osamu Yamasaki; Takehiro Tanaka; Fumio Otsuka
Journal:  Case Rep Oncol       Date:  2018-08-17

8.  The Entire Intestinal Tract Surveillance Using Capsule Endoscopy after Immune Checkpoint Inhibitor Administration: A Prospective Observational Study.

Authors:  Keitaro Shimozaki; Kenro Hirata; Sara Horie; Akihiko Chida; Kai Tsugaru; Yukie Hayashi; Kenta Kawasaki; Ryoichi Miyanaga; Hideyuki Hayashi; Ryuichi Mizuno; Takeru Funakoshi; Naoki Hosoe; Yasuo Hamamoto; Takanori Kanai
Journal:  Diagnostics (Basel)       Date:  2021-03-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.